OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Clinical Laboratory Analysis is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
	692
Automated Morphologic Differentiation Between Iron Deficiency Anemia and Thalassemia	160
Evaluation of chromosomal abnormalities in the postnatal cohort: A single‐center study on 14,242 patients	86
A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug‐Resistant and Extensively Drug‐Resistant Mycobacterium tuberculosis	68
Misdiagnosis of a patient with congenital dysfibrinogenemia: A case report and literature review	65
Corrigendum	63
Issue Information	55
Deciphering the Role of Calcium Signaling Pathway‐Associated Single Nucleotide Variants in Susceptibility to Hypertension	54
A Large‐Scale Retrospective Study of Serum Des‐Gamma‐Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on Specificity	48
Analytical and clinical evaluation of the light‐initiated chemiluminescent assays for measurement of human thyroid hormones	47
Soluble Triggering Receptors on Myeloid Cells‐1 Could Be a Potential Biomarker for Disease Activity in Familial Mediterranean Fever	46
Performance evaluation of the i‐Smart 300E cartridge for point‐of‐care electrolyte measurement in serum and plasma	46
IL‐6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID‐19 patients	44
hsa_circ_0115355 promotes pancreatic β‐cell function in patients with type 2 diabetes through the miR‐145/SIRT1 axis	42
JNK pathway‐associated phosphatase illustrates low expression and negative correlations with inflammation, disease activity, and T‐helper 17 cells in inflammatory bowel disease children	41
Ultra‐Sensitive Quantification of Indoxyl Sulfate and 3‐Carboxy‐4‐Methyl‐5‐Propyl‐2‐Furanpropanoic Acid in Plasma Using Ultra‐Performance Liquid Chromatography Coupled to Quadrupole Time‐of‐Flight Mas	40
	40
CYP2S1 rs338599 polymorphism confers reduced risk to anti‐tuberculosis drug‐induced liver injury and may be a novel marker for its risk prediction	38
Circulating tumor necrosis factor‐α, interleukin‐1β, and interleukin‐17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients	36
Exploration of the Clinical Effect of Different Autotransfusion Methods on Patients With Femoral Shaft Fracture Surgery	35
Proxalutamide for the treatment of COVID‐19 rebound following Paxlovid treatment: Report of four cases and review of the literature	34
Hsa_circ_0008726 regulates the proliferation, migration, and invasion of trophoblast cells in preeclampsia through modulating the miR‐1290‐LHX6 signaling pathway	34
Optimizing Markers for Chronic Lymphocytic Leukemia Diagnosis by Flow Cytometry: Results From the Nationwide Thai Lymphoma Study Group	33
Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis	33
Diagnostic value of total testosterone and free androgen index measured by LC–MS/MS for PCOS and insulin resistance	33

A dilute‐and‐shoot liquid chromatography–tandem mass spectrometry method for urinary 18‐hydroxycortisol quantification and its application in establishing reference intervals	32
Development of six immune‐related lncRNA signature prognostic model for smoking‐positive lung adenocarcinoma	32
Establishing Decisional Cutoff Values of Neurofilament Light Chains in Cerebrospinal Fluid Measured by Fully Automated Chemiluminescent Enzyme Immunoassay	32
Aberrant blood MALT1 and its relevance with multiple organic dysfunctions, T helper cells, inflammation, and mortality risk of sepsis patients	31
Validation of high concentrated thrombin time assay for unfractionated heparin monitoring	31
Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer	31
The usefulness of the estimated average glucose/fasting blood glucose ratio for pancreatic β‐cell function assessment in hyperglycemia during health checkups	31